Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Pharm. 2007 May-Jun;4(3):301-9. Epub 2007 May 4.

An overview of pharmaceutical cocrystals as intellectual property.

Author information

1
Jones Day, 222 East 41st Street, New York, New York 10017, USA. avtrask@jonesday.com

Abstract

This review article focuses on the interaction among certain scientific, legal, and regulatory aspects of pharmaceutical crystal forms. The article offers an analysis of pharmaceutical cocrystals as patentable inventions by drawing upon recent scientific developments in the field. Several potential commercial advantages of pharmaceutical cocrystals are highlighted, and a number of recent court decisions involving salient issues are summarized. The article provides an outlook on how the developing field of cocrystallization may impact the pharmaceutical intellectual property landscape.

PMID:
17477544
DOI:
10.1021/mp070001z
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society
    Loading ...
    Support Center